1. Volume 8, Issue 6, Pages 519-529 (June 2009)
NORdic trial of oral Methylprednisolone as add-on therapy to Interferon beta-1a for treatment of relapsing-remitting Multiple Sclerosis (NORMIMS study): a randomised, placebo-controlled trial 
Per Soelberg Sorensen, MD, Svein Ivar Mellgren, MD, Anders Svenningsson, MD, Irina Elovaara, MD, Jette Lautrup Frederiksen, MD, Antonie Giaever Beiske, MD, Kjell-Morten Myhr, MD, Lise Vejby Søgaard, PhD, Inge Christoffer Olsen, PhD, Magnhild Sandberg- Wollheim, MD 
The Lancet Neurology 
Volume 8, Issue 6, Pages (June 2009)
DOI: /S (09)
Copyright © 2009 Elsevier Ltd Terms and Conditions

2. Figure 1 Trial profile ITT=intention to treat.
The Lancet Neurology 2009 8, DOI: ( /S (09) )
Copyright © 2009 Elsevier Ltd Terms and Conditions

3. Figure 2
Kaplan–Meier plots of time to sustained progression of disability
The Lancet Neurology 2009 8, DOI: ( /S (09) )
Copyright © 2009 Elsevier Ltd Terms and Conditions